Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Alzheimer's Disease

  Free Subscription


Articles published in Lancet Neurol

Retrieve available abstracts of 67 articles:
HTML format
Text format



Single Articles


    June 2018
  1. KNUDSEN K, Fedorova TD, Hansen AK, Sommerauer M, et al
    In-vivo staging of pathology in REM sleep behaviour disorder: a multimodality imaging case-control study.
    Lancet Neurol. 2018 Jun 1. pii: S1474-4422(18)30162.
    PubMed     Text format     Abstract available


    May 2018
  2. DUFOUIL C, Glymour MM
    Prediction to prevention in Alzheimer's disease and dementia.
    Lancet Neurol. 2018;17:388-389.
    PubMed     Text format    


    March 2018
  3. VAN DER LEE SJ, Wolters FJ, Ikram MK, Hofman A, et al
    The effect of APOE and other common genetic variants on the onset of Alzheimer's disease and dementia: a community-based cohort study.
    Lancet Neurol. 2018 Mar 16. pii: S1474-4422(18)30053.
    PubMed     Text format     Abstract available


  4. BALLARD C, Banister C, Khan Z, Cummings J, et al
    Evaluation of the safety, tolerability, and efficacy of pimavanserin versus placebo in patients with Alzheimer's disease psychosis: a phase 2, randomised, placebo-controlled, double-blind study.
    Lancet Neurol. 2018;17:213-222.
    PubMed     Text format     Abstract available


  5. SCHNEIDER LS
    Pimavanserin for patients with Alzheimer's disease psychosis.
    Lancet Neurol. 2018;17:194-195.
    PubMed     Text format    


    February 2018
  6. DUBOIS B, Epelbaum S, Nyasse F, Bakardjian H, et al
    Cognitive and neuroimaging features and brain beta-amyloidosis in individuals at risk of Alzheimer's disease (INSIGHT-preAD): a longitudinal observational study.
    Lancet Neurol. 2018 Feb 27. pii: S1474-4422(18)30029.
    PubMed     Text format     Abstract available


  7. WESTON PSJ, Nicholas JM, Henley SMD, Liang Y, et al
    Accelerated long-term forgetting in presymptomatic autosomal dominant Alzheimer's disease: a cross-sectional study.
    Lancet Neurol. 2018;17:123-132.
    PubMed     Text format     Abstract available


  8. REIMAN EM
    Long-term forgetting in preclinical Alzheimer's disease.
    Lancet Neurol. 2018;17:104-105.
    PubMed     Text format    


    January 2018
  9. GORDON BA, Blazey TM, Su Y, Hari-Raj A, et al
    Spatial patterns of neuroimaging biomarker change in individuals from families with autosomal dominant Alzheimer's disease: a longitudinal study.
    Lancet Neurol. 2018 Jan 31. pii: S1474-4422(18)30028.
    PubMed     Text format     Abstract available


  10. TIJMS BM, Visser PJ
    Capturing the Alzheimer's disease pathological cascade.
    Lancet Neurol. 2018 Jan 31. pii: S1474-4422(18)30043.
    PubMed     Text format    


  11. AUGUSTIN K, Khabbush A, Williams S, Eaton S, et al
    Mechanisms of action for the medium-chain triglyceride ketogenic diet in neurological and metabolic disorders.
    Lancet Neurol. 2018;17:84-93.
    PubMed     Text format     Abstract available


    December 2017
  12. THE LANCET NEUROLOGY
    Alzheimer's disease: evolution of research diagnostic criteria.
    Lancet Neurol. 2017;16:945.
    PubMed     Text format    


    November 2017
  13. HALLIDAY G
    Pathology and hippocampal atrophy in Alzheimer's disease.
    Lancet Neurol. 2017;16:862-864.
    PubMed     Text format    


    October 2017
  14. SOININEN H, Solomon A, Visser PJ, Hendrix SB, et al
    24-month intervention with a specific multinutrient in people with prodromal Alzheimer's disease (LipiDiDiet): a randomised, double-blind, controlled trial.
    Lancet Neurol. 2017 Oct 30. pii: S1474-4422(17)30332.
    PubMed     Text format     Abstract available


  15. YASSINE HN
    Targeting prodromal Alzheimer's disease: too late for prevention?
    Lancet Neurol. 2017 Oct 30. pii: S1474-4422(17)30372.
    PubMed     Text format    


    September 2017
  16. JOSEPHS KA, Dickson DW, Tosakulwong N, Weigand SD, et al
    Rates of hippocampal atrophy and presence of post-mortem TDP-43 in patients with Alzheimer's disease: a longitudinal retrospective study.
    Lancet Neurol. 2017 Sep 11. pii: S1474-4422(17)30284.
    PubMed     Text format     Abstract available


  17. DROUIN E, Drouin G
    The first report of Alzheimer's disease.
    Lancet Neurol. 2017;16:687.
    PubMed     Text format    


    August 2017
  18. FRISONI GB, Boccardi M, Barkhof F, Blennow K, et al
    Strategic roadmap for an early diagnosis of Alzheimer's disease based on biomarkers.
    Lancet Neurol. 2017;16:661-676.
    PubMed     Text format     Abstract available


  19. COLEY N, Andrieu S
    Lessons from the Multidomain Alzheimer Preventive Trial - Authors' reply.
    Lancet Neurol. 2017;16:586.
    PubMed     Text format    


  20. YASSINE HN, Schneider LS
    Lessons from the Multidomain Alzheimer Preventive Trial.
    Lancet Neurol. 2017;16:585-586.
    PubMed     Text format    


  21. ESCOTT-PRICE V, Jones L
    Genomic profiling and diagnostic biomarkers in Alzheimer's disease.
    Lancet Neurol. 2017;16:582-583.
    PubMed     Text format    


  22. ISAAC MT, Vamvakas S, Isaac MB
    Diagnostic biomarkers for Alzheimer's disease: a regulatory view.
    Lancet Neurol. 2017;16:580-581.
    PubMed     Text format    


    June 2017
  23. KIRBY T
    Eric Reiman: aiming to prevent Alzheimer's disease.
    Lancet Neurol. 2017 Jun 30. pii: S1474-4422(17)30216.
    PubMed     Text format    


    May 2017
  24. HARDY J
    Membrane damage is at the core of Alzheimer's disease.
    Lancet Neurol. 2017;16:342.
    PubMed     Text format    


    April 2017
  25. VOSSEL KA, Tartaglia MC, Nygaard HB, Zeman AZ, et al
    Epileptic activity in Alzheimer's disease: causes and clinical relevance.
    Lancet Neurol. 2017;16:311-322.
    PubMed     Text format     Abstract available


    February 2017
  26. THE LANCET NEUROLOGY
    Solanezumab: too late in mild Alzheimer's disease?
    Lancet Neurol. 2017;16:97.
    PubMed     Text format    


    January 2017
  27. SCHNEIDER L
    Alzheimer's disease and other dementias: update on research.
    Lancet Neurol. 2017;16:4-5.
    PubMed     Text format    


  28. ATTEMS J
    Alzheimer's disease pathology in synucleinopathies.
    Lancet Neurol. 2017;16:22-23.
    PubMed     Text format    


  29. IRWIN DJ, Grossman M, Weintraub D, Hurtig HI, et al
    Neuropathological and genetic correlates of survival and dementia onset in synucleinopathies: a retrospective analysis.
    Lancet Neurol. 2017;16:55-65.
    PubMed     Text format     Abstract available


    December 2016
  30. PANZA F, Logroscino G
    Anti-tau vaccine in Alzheimer's disease: a tentative step.
    Lancet Neurol. 2016 Dec 9. pii: S1474-4422(16)30340.
    PubMed     Text format    


  31. NOVAK P, Schmidt R, Kontsekova E, Zilka N, et al
    Safety and immunogenicity of the tau vaccine AADvac1 in patients with Alzheimer's disease: a randomised, double-blind, placebo-controlled, phase 1 trial.
    Lancet Neurol. 2016 Dec 9. pii: S1474-4422(16)30331.
    PubMed     Text format     Abstract available


    October 2016
  32. RYAN NS, Nicholas JM, Weston PS, Liang Y, et al
    Clinical phenotype and genetic associations in autosomal dominant familial Alzheimer's disease: a case series.
    Lancet Neurol. 2016 Oct 21. pii: S1474-4422(16)30193.
    PubMed     Text format     Abstract available


  33. VAN DER FLIER WM
    Clinical heterogeneity in familial Alzheimer's disease.
    Lancet Neurol. 2016 Oct 21. pii: S1474-4422(16)30275.
    PubMed     Text format    


  34. TANG M, Ryman DC, McDade E, Jasielec MS, et al
    Neurological manifestations of autosomal dominant familial Alzheimer's disease: a comparison of the published literature with the Dominantly Inherited Alzheimer Network observational study (DIAN-OBS).
    Lancet Neurol. 2016 Oct 21. pii: S1474-4422(16)30229.
    PubMed     Text format     Abstract available


    August 2016
  35. MORGAN J
    An orange and Alzheimer's disease?
    Lancet Neurol. 2016;15:911.
    PubMed     Text format    


    July 2016
  36. BISCHOF GN
    Alzheimer's disease risk: amyloid versus neurodegeneration.
    Lancet Neurol. 2016 Jul 19. pii: S1474-4422(16)30138.
    PubMed     Text format    


  37. BURNHAM SC, Bourgeat P, Dore V, Savage G, et al
    Clinical and cognitive trajectories in cognitively healthy elderly individuals with suspected non-Alzheimer's disease pathophysiology (SNAP) or Alzheimer's disease pathology: a longitudinal study.
    Lancet Neurol. 2016 Jul 19. pii: S1474-4422(16)30125.
    PubMed     Text format     Abstract available


  38. MORGAN J
    Early onset Alzheimer's disease: many mountains to climb.
    Lancet Neurol. 2016;15:798.
    PubMed     Text format    


  39. CUYVERS E, Sleegers K
    Genetic variations underlying Alzheimer's disease: evidence from genome-wide association studies and beyond.
    Lancet Neurol. 2016;15:857-68.
    PubMed     Text format     Abstract available


    June 2016
  40. NELSON PT
    Cerebrovascular pathology and Alzheimer's disease.
    Lancet Neurol. 2016 Jun 13. pii: S1474-4422(16)30038.
    PubMed     Text format    


  41. ARVANITAKIS Z, Capuano AW, Leurgans SE, Bennett DA, et al
    Relation of cerebral vessel disease to Alzheimer's disease dementia and cognitive function in elderly people: a cross-sectional study.
    Lancet Neurol. 2016 Jun 13. pii: S1474-4422(16)30029.
    PubMed     Text format     Abstract available


  42. MORGAN J
    "A big decision": living with early onset familial Alzheimer's disease.
    Lancet Neurol. 2016;15:671.
    PubMed     Text format    


  43. TARIOT PN, Langbaum JB, Reiman EM
    What are we willing to accept for preventing Alzheimer's disease? - Investigators' reply.
    Lancet Neurol. 2016;15:660-1.
    PubMed     Text format    


  44. CESARI M, Vanacore N, Canevelli M
    What are we willing to accept for preventing Alzheimer's disease?
    Lancet Neurol. 2016;15:659-60.
    PubMed     Text format    


  45. FRISONI GB, Hansson O
    Clinical validity of CSF biomarkers for Alzheimer's disease: necessary indeed, but sufficient?
    Lancet Neurol. 2016;15:650-1.
    PubMed     Text format    


  46. THE LANCET NEUROLOGY
    Finding a cure for Alzheimer's disease starts with prevention.
    Lancet Neurol. 2016;15:649.
    PubMed     Text format    


    April 2016
  47. OLSSON B, Lautner R, Andreasson U, Ohrfelt A, et al
    CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis.
    Lancet Neurol. 2016 Apr 8. pii: S1474-4422(16)00070.
    PubMed     Text format     Abstract available


  48. WINBLAD B, Amouyel P, Andrieu S, Ballard C, et al
    Defeating Alzheimer's disease and other dementias: a priority for European science and society.
    Lancet Neurol. 2016;15:455-532.
    PubMed     Text format    


  49. MAZURE CM, Swendsen J
    Sex differences in Alzheimer's disease and other dementias.
    Lancet Neurol. 2016;15:451-2.
    PubMed     Text format    


  50. QUAGLIO G, Brand H, Dario C
    Fighting dementia in Europe: the time to act is now.
    Lancet Neurol. 2016;15:452-4.
    PubMed     Text format    


    December 2015
  51. WRAY S, Fox NC
    Stem cell therapy for Alzheimer's disease: hope or hype?
    Lancet Neurol. 2015 Dec 15. pii: S1474-4422(15)00382.
    PubMed     Text format    


  52. HUNSBERGER JG, Rao M, Kurtzberg J, Bulte JW, et al
    Accelerating stem cell trials for Alzheimer's disease.
    Lancet Neurol. 2015 Dec 15. pii: S1474-4422(15)00332.
    PubMed     Text format     Abstract available


    November 2015
  53. VOS SJ, Fagan AM
    Alzheimer's disease biomarker states.
    Lancet Neurol. 2015 Nov 17. pii: S1474-4422(15)00335.
    PubMed     Text format    


    October 2015
  54. HOWARD R, McShane R, Lindesay J, Ritchie C, et al
    Nursing home placement in the Donepezil and Memantine in Moderate to Severe Alzheimer's Disease (DOMINO-AD) trial: secondary and post-hoc analyses.
    Lancet Neurol. 2015 Oct 26. pii: S1474-4422(15)00258.
    PubMed     Text format     Abstract available


  55. WIMO A
    Long-term effects of Alzheimer's disease treatment.
    Lancet Neurol. 2015 Oct 26. pii: S1474-4422(15)00302.
    PubMed     Text format    


    September 2015
  56. LAUNER LJ
    Preventing Alzheimer's disease is difficult.
    Lancet Neurol. 2015;14:872-4.
    PubMed     Text format    


    August 2015
  57. TEIPEL S, Drzezga A, Grothe MJ, Barthel H, et al
    Multimodal imaging in Alzheimer's disease: validity and usefulness for early detection.
    Lancet Neurol. 2015 Aug 26. pii: S1474-4422(15)00093.
    PubMed     Text format     Abstract available


  58. GROSSMAN M
    Integrated multimodal imaging in neurodegenerative disease.
    Lancet Neurol. 2015 Aug 26. pii: S1474-4422(15)00182.
    PubMed     Text format    


  59. KIRBY T
    William Klunk: imaging Alzheimer's disease in vivo.
    Lancet Neurol. 2015;14:791.
    PubMed     Text format    


  60. THE LANCET NEUROLOGY
    Alzheimer's disease: a time for cautious optimism.
    Lancet Neurol. 2015;14:779.
    PubMed     Text format    


    July 2015
  61. ANDRIEU S, Coley N, Lovestone S, Aisen PS, et al
    Prevention of sporadic Alzheimer's disease: lessons learned from clinical trials and future directions.
    Lancet Neurol. 2015 Jul 23. pii: S1474-4422(15)00153.
    PubMed     Text format     Abstract available


  62. BIANCHI A
    Sir Terry Pratchett: shaking hands with Death.
    Lancet Neurol. 2015;14:691.
    PubMed     Text format    


    June 2015
  63. FARRER LA
    Expanding the genomic roadmap of Alzheimer's disease.
    Lancet Neurol. 2015 Jun 30. pii: S1474-4422(15)00146.
    PubMed     Text format    


  64. CUYVERS E, De Roeck A, Van den Bossche T, Van Cauwenberghe C, et al
    Mutations in ABCA7 in a Belgian cohort of Alzheimer's disease patients: a targeted resequencing study.
    Lancet Neurol. 2015 Jun 30. pii: S1474-4422(15)00133.
    PubMed     Text format     Abstract available


  65. FRISONI GB, Visser PJ
    Biomarkers for Alzheimer's disease: a controversial topic.
    Lancet Neurol. 2015 Jun 29. pii: S1474-4422(15)00150.
    PubMed     Text format    


  66. YAU WW, Tudorascu DL, McDade EM, Ikonomovic S, et al
    Longitudinal assessment of neuroimaging and clinical markers in autosomal dominant Alzheimer's disease: a prospective cohort study.
    Lancet Neurol. 2015 Jun 29. pii: S1474-4422(15)00135.
    PubMed     Text format     Abstract available


    May 2015
  67. HOLMES D
    Stuart Lipton: UFOs and flying tigers.
    Lancet Neurol. 2015;14:464.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Alzheimer's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: